<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Vaccine Candidates in Development against SARS-CoV-2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Vaccine Type</th>
    <th>Platform</th>
    <th>Protein Target</th>
    <th>Stage</th>
    <th>Clinical Trial Designation</th>
    <th>Company or Institution</th>
    <th>Vaccine Name</th>
    <th>Status</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>mRNA</td>
    <td>Lipid-encapsulated mRNA</td>
    <td>S</td>
    <td>Phase 1</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04283461" id="intref0075" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04283461</ext-link> (45 subjects)
    </td>
    <td>Moderna</td>
    <td>mRNA-1273</td>
    <td>Recruiting</td>
   </tr>
   <tr>
    <td>DNA</td>
    <td>DNA plasmid</td>
    <td>S</td>
    <td>Phase 1</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04336410" id="intref0080" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04336410</ext-link> (40 subjects)
    </td>
    <td>Inovio Pharmaceuticals</td>
    <td>INO-4800</td>
    <td>Recruiting</td>
   </tr>
   <tr>
    <td>Human adenovirus (Ad5)</td>
    <td>Viral-vectored</td>
    <td>S</td>
    <td>Phase 1</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04313127" id="intref0085" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04313127</ext-link> (108 subjects)
    </td>
    <td>CanSino Biologics</td>
    <td>Ad5-nCoV</td>
    <td>Active</td>
   </tr>
   <tr>
    <td>Chimpanzee adenovirus</td>
    <td>Viral-vectored</td>
    <td>S</td>
    <td>Phase 1/2</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04324606" id="intref0090" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04324606</ext-link> (510 subjects)
    </td>
    <td>University of Oxford</td>
    <td>ChAdOx1 nCoV-19</td>
    <td>Planned (4/20)</td>
   </tr>
   <tr>
    <td>Spike protein</td>
    <td>Bacterially produced soluble protein (oral)</td>
    <td>S</td>
    <td>Phase 1</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04334980" id="intref0095" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04334980</ext-link> (84 subjects)
    </td>
    <td>Symvivo Corporation</td>
    <td>bacTRL-Spike</td>
    <td>Planned (4/30)</td>
   </tr>
   <tr>
    <td>BCG vaccine</td>
    <td>Immune stimulatory</td>
    <td>None</td>
    <td>Phase 3</td>
    <td>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04327206" id="intref0100" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04327206</ext-link> (4170 subjects)
     <break/>
     <ext-link ext-link-type="ClinicalTrials.gov" xlink:href="NCT04328441" id="intref0105" xmlns:xlink="http://www.w3.org/1999/xlink">NCT04328441</ext-link> (1000 subjects)
    </td>
    <td>Murdoch Childrens Research Institute
     <break/>University Medical Center, Netherlands
    </td>
    <td>BCG vaccine</td>
    <td>Recruiting</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Information adapted from 
    <ext-link ext-link-type="uri" xlink:href="https://ClinicalTrials.gov" id="intref0110" xmlns:xlink="http://www.w3.org/1999/xlink">https://ClinicalTrials.gov</ext-link>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
